Intravitreal Bevacizumab vs Laser Treatment in Type 1 Retinopathy of Prematurity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Intravitreal Bevacizumab Versus Laser Treatment in Type 1 Retinopathy of Prematurity: Report on Fluorescein Angiographic Findings
Ophthalmology 2014 Jul 04;[EPub Ahead of Print], D Lepore, GE Quinn, F Molle, A Baldascino, L Orazi, M Sammartino, V Purcaro, C Giannantonio, P Papacci, C RomagnoliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.